Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to…
PRESS RELEASEAB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY MARCH 4, 2024 FROM 6.30PM TO 7.30PM CETParis, 1 March, 2024, 6pm CETAB Science SA(Euronext – FR0010557264 – AB) will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET. The agenda of this live webcast will be to provide status and perspective on the following topics: Conditional approval of masitinib in ALS with EMA and Health CanadaPartnership strategyMasitinib platform clinical development...
Nasdaq GlobeNewswire
01/03/2024
Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024
ORION CORPORATIONSTOCK EXCHANGE RELEASE – CHANGES IN COMPANY'S OWN SHARES 1 MARCH 2024 at 18.50 EET Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024 In accordance with a decision by the Board of Directors, Orion Corporation has on 1 March 2024 transferred altogether 150,118 Orion Corporation B shares held by the company as a share reward for earning period 2021–2023 to the persons belonging to the Share-based Incentive Plan of the Orion Group. The transfer is...
Nasdaq GlobeNewswire
01/03/2024
Number of voting rights as of February 29, 2024
Nicox SA Société anonyme with a registered capital of € 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 Biot R.C.S. ANTIBES 403.942.642 On March 1 st, 2024, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlement général of the l'AMF) As of February 29, 2024Total number of...
Nasdaq GlobeNewswire
01/03/2024
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12158123 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12158123 Browse in-depth TOC on "Pipette Calibrators Market" 239 - Tables 40 - Figures 234 - Pages Pipette Calibrators Market Scope: Devices segment is expected to account for the largest share in 2022. The pipette calibrators market, by type, has been segmented into...
PR Newswire
01/03/2024
Coloplast A/S - Trading in Coloplast shares by board members, executives or…
Please see enclosed pdf. Attachment 01032024_trading_in_shares_ARA
Nasdaq GlobeNewswire
01/03/2024
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib…
"Based on the clinical and preclinical data generated to date, we believe exarafenib may present a best-in-class product profile as a pan-RAF inhibitor targeting solid tumors such as NRAS mutant melanoma, for which there are currently no approved targeted therapies. The addition of exarafenib and other pan-RAF program assets from Kinnate is complementary to our existing BRAF and MEK inhibitors portfolio with encorafenib and binimetinib. This acquisition continues to expand our efforts in…
PR Newswire
01/03/2024
Calliditas Therapeutics to Attend Investor Conferences in March
Jefferies Biotech on the Bay Summit, Wednesday, March 13, 2024 in Miami, FL, one-on-one meetings will be available. Jefferies Biotech on the Bay Summit,Wednesday, March 13, 2024inMiami, FL, one-on-one meetings will be available. Leerink Partners Global Biopharma ConferenceonMarch 12, 2024inMiami, FL. For further information, please contact : Åsa Hillsten, Head of IR & Sustainability, Calliditas Tel.: +46 76 403 35 43, Email:asa.hillsten@calliditas.com ...
PR Newswire
01/03/2024
iTeos to Participate in Upcoming Investor Conferences
Cowen 44 thAnnual Healthcare ConferenceFormat: Presentation and one-on-one investor meetings Date: Wednesday, March 6, 2024 Time: 1:30 PM ET Location: Boston, M.A. Leerink Partners Global Biopharma ConferenceFormat: One-on-one investor meetings Date: Monday, March 11, 2024 Location: Miami, F.L.A live webcast of the conference presentation will be available on the Investors section of the company's website atwww.iteostherapeutics.com. An archived replay will be available for...
Nasdaq GlobeNewswire
01/03/2024
Powerful Medical Secures €7.5M in Funding from European Innovation Council to…
Powerful Medical, a pioneering medical device manufacturer, proudly announces being selected to receive a €2.5 million grant and a follow-on €5 million investment from the European Innovation Council (EIC).Chosen from over one thousand applicants , Powerful Medical stands out as a driver of innovation focused on transforming the field of cardiovascular diagnostics.AALST, Belgium, March01, 2024(GLOBE NEWSWIRE) -- Powerful Medical leads the battle againstcardiovascular...
Nasdaq GlobeNewswire
01/03/2024
Toray ACS Exhibits at Texprocess in Frankfurt, Germany
Under our purpose "Uplifting the fashion industry, with our love for fashion creation and the power of IT.", we are proud to offer cutting-edge CAD software to customers worldwide, boasting the No. 1 market share for 2D pattern making software in Japan. Under our purpose "Uplifting the fashion industry, with our love for fashion creation and the power of IT.", we are proud to offer cutting-edge CAD software to customers worldwide, boasting the No. 1 market share for 2D…
PR Newswire
01/03/2024
Walden Group, one of the main players in European healthcare logistics…
With a 2.4% share of the global market in terms of drug consumption,Italyhas always been a focus of Walden; the high level of expertise in the field of R&D, especially in the biotech sector, are among the main reasons that convinced the group in this decision. As a major player in the pharmaceutical supply chain and a provider of distribution solutions, the acquisitions have proven to be essential to enter the Italian market. In addition,Italyis the third European...
PR Newswire
01/03/2024
United Imaging Intelligence Unveiled Next-Generation Radiology Solutions at ECR…
Amidst the rapid transformation of the medical technology landscape driven by foundation models, UII adopts these crucial frameworks to enhance 'Next Generation Radiology'. A vital aspect of this advancement is medical imaging AI research. At ECR 2024, UII introduced uAI SAT, an innovative AI-driven annotation tool hosted on its biomedical research platform. Utilizing a large medical image model, uAI SAT enhances intelligent interactive segmentation, significantly shortening annotation times…
PR Newswire
01/03/2024
Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative…
Accurate measurement of the volume and distribution of different tissue types in the brain is important for diagnosing brain disease. However, visual assessments of MR images are often subjective, and lack the necessary accuracy while measuring tissue volume from 2D image slices is virtually impossible. Smart Quant Neuro 3D leverages the power of AI to provide fully verified automatic and precise 3D segmentation and volume measurement of brain tissue such as white matter, gray matter…
PR Newswire
01/03/2024
'An Urgent Public Health Necessity' - National Institute for Play Releases New…
"The pandemic and its aftermath, our nation's extreme political polarization, global geopolitical conflicts and the climate crisis contribute to unprecedented, widespread levels of anxiety, depression, addiction, and hopelessness. Play is part of the solution," Dr. Brown writes in the Foreword. "The pandemic and its aftermath, our nation's extreme political polarization, global geopolitical conflicts and the climate crisis contribute to unprecedented, widespread levels of anxiety…
PR Newswire
29/02/2024
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech &…
Nyxoah to Participate in the Oppenheimer 34 thAnnual Healthcare MedTech & Services ConferenceMont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Oppenheimer 34 thAnnual Healthcare...
Nasdaq GlobeNewswire
29/02/2024
GENFIT Announces Revenues and Cash Position as of December 31, 2023
Cash and cash equivalents totaled €77.8 million as of December 31, 2023Revenues amounted to €28.6 million as of December 31, 2023 including a milestone payment of €13.3 million Upcoming FDA PDUFA action date for elafibranor in PBC: June 10, 2024 Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 29, 2024-GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and...
Nasdaq GlobeNewswire
29/02/2024
Alvotech Appoints Interim Chief Quality Officer
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Christina Siniscalchi will join its corporate leadership team as interim Chief Quality Officer. Christina succeeds Sandra Casaca, who is leaving the company as a part of other organizational changes. Christina Siniscalchi has for over ten years served in senior quality positions for Alvogen and its manufacturing site in Norwich,...
Nasdaq GlobeNewswire
29/02/2024
Commercial Door Market Revenue Witnessing Upward Surge, While the market in the…
Market players in the US commercial doors market are adopting several strategies. They focus on research and development to stay at the forefront of technological innovations, ensuring that their product portfolios align with the demand for automatic, sustainable, and technologically enhanced doors. Additionally, they engage in strategic partnerships and collaborations to integrate new technologies seamlessly. Embracing sustainability in manufacturing processes aligns with market demands and…
PR Newswire
29/02/2024
Rising Use of Rigid Foam in the Building & Construction Industry Drives Market…
Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19159 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19159 The rigid foam market's upward trajectory is being nurtured by its use in the construction sector. The insulation, as well as the safety provided by the materials for buildings, is endearing the product to...
PR Newswire
29/02/2024
Reverse stock split
Press release Ecully, February 29, 2024 – 6:00 p.m. Effective date of the Spineway reverse stock split Spineway announces the completion of the reverse stock split by exchanging 1 new share of 4.00 euros par value for 2,000 old shares of 0.002 euro par value. This transaction, which was carried out pursuant to a decision by the Company's shareholders at an Extraordinary General Meeting held on November 10, 2023, took effect on February 27, 2024.The old Spineway shares with...
Nasdaq GlobeNewswire
29/02/2024
NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting…
Company announcement no. 3 – 24 29 February 2024 NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2024 The Annual General Meeting of NTG Nordic Transport Group A/S will be held onThursday, 21 March 2024, at 14:00 (CET) at Glostrup Park Hotel, Hovedvejen 41, 2600 Glostrup, Denmark. The notice to convene the Annual General Meeting including Appendix 1 is attached. Additional information For additional information, please contact:Christian D...
Nasdaq GlobeNewswire
29/02/2024
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy…
Payments to be made in connection with the DOJ resolutions will be made in accordance with the previously disclosed global economic settlement-in-principle, which also resolves claims from the Internal Revenue Service, included in the Company's proposed Plan of Reorganization originally filed on December 19, 2023. Payments to be made in connection with the DOJ resolutions will be made in accordance with the previously disclosed global economic settlement-in-principle, which also resolves…
PR Newswire
29/02/2024
NTG Nordic Transport Group Annual Report for 2023
Company announcement no. 2 – 2429 February 2024 NTG Nordic Transport Group Annual Report for 2023 NTG Nordic Transport Group A/S (“NTG”) has today published the 2023 annual report. Selected financial highlights are presented below: Full year Q4(DKKm) 2023 2022 20232022 Net revenue 8,33810,224 2,0012,496Gross profit 1,8662,012 463518Operating profit before special items (adj. EBIT) 630758 171...
Nasdaq GlobeNewswire
29/02/2024
Transactions with shares and linked securities in Genmab A/S made by managerial…
Company Announcement COPENHAGEN, Denmark; February 29, 2024 –Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.The company's managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to...
Nasdaq GlobeNewswire
29/02/2024
Altri Comunicati
